In-house AI organization for new-drug candidate discovery

Celltrion said it set up a dedicated AI-based new-drug organization the previous year and is applying AI in stages, with bioinformatics, to finding, validating and optimizing new-drug target candidates. The release also says the company is pursuing open innovation with external AI specialist firms, which it does not name.